Psychometric Validation of the Competitive Attention Test
NCT ID: NCT03942835
Last Updated: 2021-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
26 participants
INTERVENTIONAL
2020-01-21
2021-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This project proposes:
* a test-retest procedure in healthy subjects aged from 6 to 90 year-old;
* testing in attention deficit hyperactivity disorder (ADHD) patients before psychostimulant treatment;
* testing in attention deficit hyperactivity disorder (ADHD) patients before psychostimulant treatment.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy participants aged from 6 to 90 year-old
experience 1 : Competitive attention test in healthy participants
Comparison of behavioral measures (reaction times and percentage of correct responses) obtained twice with the CAT test in healthy participants (2 to 6 weeks apart).
patients with ADHD with no treatment
patients with ADHD aged from 6 to 90 year-old with no treatment
experience 2 : Competitive attention test in patients with ADHD with no treatment
Behavioral (reaction times and percentage of correct responses) and Electroencephalography (EEG) measures obtained with the CAT test in patients with ADHD with no treatment.
patients with ADHD with treatment
patients with ADHD aged from 6 to 90 year-old with psychostimulant treatment (Methylphenidate)
experience 2 : Competitive attention test in patients with ADHD with no treatment
Behavioral (reaction times and percentage of correct responses) and Electroencephalography (EEG) measures obtained with the CAT test in patients with ADHD with no treatment.
experience 3 :Competitive attention test in patients with ADHD with psychostimulant treatment
Behavioral (reaction times and percentage of correct responses) and EEG measures obtained with the CAT test in patients with ADHD before and after psychostimulant treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
experience 1 : Competitive attention test in healthy participants
Comparison of behavioral measures (reaction times and percentage of correct responses) obtained twice with the CAT test in healthy participants (2 to 6 weeks apart).
experience 2 : Competitive attention test in patients with ADHD with no treatment
Behavioral (reaction times and percentage of correct responses) and Electroencephalography (EEG) measures obtained with the CAT test in patients with ADHD with no treatment.
experience 3 :Competitive attention test in patients with ADHD with psychostimulant treatment
Behavioral (reaction times and percentage of correct responses) and EEG measures obtained with the CAT test in patients with ADHD before and after psychostimulant treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age from 18 to 90 year-old
* Informed consent to participate in the study
* No neurological or psychiatric disorder
* No history of neuro-psychiatric disorder or neurodevelopmental type dysphasia, dyslexia, dyspraxia, attention deficit disorder
healthy minor participants:
* Age from 6 to 17 year-old
* Informed consent of parents or guardians for the child's participation in the study
* No neurological or psychiatric disorder
* No history of neuro-psychiatric disorder or neurodevelopmental type dysphasia, dyslexia, dyspraxia, Attention deficit disorder
ADHD minor patients:
* Age from 6 to 17 year-old
* Informed consent of parents or guardians for the child's participation in the study
* ADHD Diagnosis with or without hyperactivity
* No psychiatric history other than ADHD.
* For Experience 3: treatment in progress.
Exclusion Criteria
* Age below 18 or above 90 year-old
* unaffiliated or non-beneficiaries of the social security scheme
healthy minor participants:
* Age below 6 or above 18 year-old
* unaffiliated or non-beneficiaries of the social security scheme
ADHD minor patients:
* Age below 6 or above 18 year-old
* unaffiliated or non-beneficiaries of the social security scheme
6 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de Recherche en Neurosciences de Lyon, INSERM U1028
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A02597-48
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL18_0376
Identifier Type: -
Identifier Source: org_study_id